0573-2621 NDC - ALAVERT ALLERGY ()

Drug Information

Product NDC: 0573-2621

Proprietary Name: ALAVERT ALLERGY

Non Proprietary Name:

Active Ingredient(s):

Administration Route(s):

Dosage Form(s):

Labeler Name:	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:	12/19/2002

No.	Package Code	Package Description	Billing Unit
1	0573-2621-13	12 BLISTER PACK in 1 CARTON (0573-2621-13) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
2	0573-2621-19	18 BLISTER PACK in 1 CARTON (0573-2621-19) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK	EA
3	0573-2621-65	60 BLISTER PACK in 1 CARTON (0573-2621-65) / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK	EA

Field Name	Field Value	Definition
PRODUCT NDC	0573-2621	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	ALAVERT ALLERGY	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE	12/19/2002	This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAME	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC	Name of Company corresponding to the labeler code segment of the Product NDC.

Export to text format icon Download this NDC record in Text format: Export

Export to text format icon Download this NDC record in Excel (CSV) format: Export

Export to text format icon Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023